To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis
Clinical trial NCT03707535 · COMPLETED
Trial details
- NCT number
- NCT03707535
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2020-03-16
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.